Results from multiple studies in lung cancer suggest that epithelial phenotype with increased ECAD gene (CDH1) or protein expression, as opposed to mesenchymal or EMT phenotype, is associated with increased sensitivity to EGFR inhibitors [40, 41, 42, 43, 44, 45]. The gene discussed is CDH1; the disease is lung cancer.